Hepatectomy for Early-stage HCC Patients With CSPH

Tongji Hospital

Status: Completed

Conditions: Portal Hypertension; HCC

Treatments: Procedure: hepatectomy

Study type: Observational

Funder types: Other

Identifiers

NCT05402644

CXPJJH11800001-2018306

Details and patient eligibility

About

Clinically significant portal hypertension (CSPH) can affect the surgical prognosis of early-stage (BCLC stage A) HCC. An additional stage, such as the BCLC stage A-B, can be considered.

Enrollment: 320 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

HCC was diagnosed by two experienced pathologists in Child-Pugh grade A/B negative resection margin Initial diagnosis of HCC in the patients

Exclusion criteria

Distant transfer Not HCC

Trial design

320 participants in 2 patient groups

Non-CSPH

Description:

BCLC stage A patients who underwent hepatectomy in the group without clinically significant portal hypertension (Non-CSPH)

Treatment:

Procedure: hepatectomy

CSPH

Description:

BCLC stage A patients who underwent hepatectomy in the group with clinically significant portal hypertension (CSPH)

Treatment:

Procedure: hepatectomy